MedPath

The efficacy of amitriptyline and melatonin in the treatment of tinnitus

Phase 2
Recruiting
Conditions
tinnitus.
Tinnitus
H93.1
Registration Number
IRCT20200825048515N48
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Ages 18 to 65
Diagnosis of subjective idiopathic tinnitus
Satisfaction to participate in the study

Exclusion Criteria

Diagnosis of psychiatric problems
Sensitivity to tricyclic antidepressants
Engaging in night shift jobs
High blood pressure
Cardiovascular diseases
Consumption of aspirin and salicylate compounds
Hypercholesterolemia and hyperlipidemia
Hyperthyroidism

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of tinnitus. Timepoint: Before and after the intervention. Method of measurement: Tinnitus handicap inventory Questionnaire (THI).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath